University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center was voted No.1 in cancer care eight times in U.S. News & World Report’s Best Hospitals between 2001 and 2011. The MD Anderson Cancer Center, located in Houston, is an incredible institution.
Thanks to the National Cancer Institute (NCI), the UT Cancer Center is gifted more than $547 million in grants and other funds. Treating patients from as early as 1941, MD Anderson is looking to change medical history through its forward-thinking emphasis on cancer prevention, treatment, and research. The hospital, one of the nation’s 40 NCI-designated Comprehensive Cancer Centers, has revolutionized the standards of education, clinical research, patient care, and cancer prevention. U.S. News named The University of Texas MD Anderson Cancer Center No. 1 in cancer care.
Much of the hospital’s acclaim has come from its success in the diagnosis and treatment of chest conditions such as pleural and pericardial mesothelioma, as well as all stages of lung and chest cancers. Dr. Anne Tsoa, a leading cancer specialist in the hospital’s Thoracic Center, is the head of the mesothelioma and thoracic chemoradiation programs, as well as a leader in the research and treatment of mesothelioma and head and neck cancers. Dr. Stephen Swisher, highly regarded figure in esophageal cancer treatment and cardiovascular surgery, also spearheads the team.
Mesothelioma and lung cancer typically require multiple stages of treatment, as these ailments don’t often react well to conventional therapies.
The doctors at MD Anderson meet often to discuss progressive approaches to healing these diseases, often involving brand new technologies and medical methods. The doctors at MD Anderson are equipped with brand-new technologies, diagnostic techniques, as well as minimally invasive treatment techniques. These techniques include endobronchial and esophageal ultrasound, positron emission tomography (PET), high resolution CT scanning, advanced bronchoscopic imaging, and drug therapies targeting specific cancer cells. As the recipient of 12 NCI-awarded Specialized Programs of Research Excellence (SPORE) grants, the hospital places an immense emphasis on cutting-edge research.
The hospital, with its physicians and scientists, is participating in roughly six-hundred projects that cover various forms of cancer. To improve diagnosis, prevention, and treatment, they are also engaged in many clinical trials. The MD Anderson Center contains a thorough record of current trials for each patient to examine and utilize.